表达完整SIV p27 Gag和HIV gp120工程化外结构域的活风疹载体可被广谱中和抗体靶向
研究以 licensed 风疹疫苗株RA27/3为载体,表达SIV Gag基质和衣壳蛋白片段(aa 41-211)或完整p27衣壳蛋白加p2(aa 136-381),以及HIV gp120工程化外结构域(eOD,172个氨基酸)。风疹/eOD-GT6和GT8载体稳定表达可结合VRC01类广谱中和抗体胚系前体和成熟形式的糖蛋白。这些载体可能用于序贯免疫策略以启动广谱中和抗体的产生。
要点
- 风疹疫苗株RA27/3可表达较大疫苗插入片段,包括Gag基质和衣壳蛋白片段或完整p27加p2。
- 风疹/eOD-GT6和GT8载体稳定表达结合VRC01类广谱中和抗体胚系前体和成熟形式的糖蛋白。
- 这些载体可能用于序贯免疫策略以启动广谱中和抗体的产生。
核心结论
- 风疹载体可表达较大疫苗插入片段,并在恒河猴中对Gag引发稳健且持久的免疫应答。
- 风疹/eOD-GT6和GT8载体稳定表达可结合VRC01类广谱中和抗体胚系前体和成熟形式的糖蛋白。
- 这些载体可能作为序贯免疫策略的一部分,用于启动广谱中和抗体的产生。
研究设计与样本
- 以 licensed 风疹疫苗株RA27/3为病毒载体表达HIV和SIV抗原。
- 载体表达Gag基质和衣壳蛋白片段(aa 41-211)或完整p27衣壳蛋白加p2(aa 136-381),以及HIV gp120工程化外结构域(eOD,172个氨基酸)。
- 在恒河猴中评估对Gag的免疫应答。
主要发现
- 风疹载体表达的较大疫苗插入片段在恒河猴中对Gag引发稳健且持久的免疫应答。
- 风疹/eOD-GT6和GT8载体稳定表达糖蛋白,该糖蛋白结合VRC01类广谱中和抗体的胚系前体和成熟形式。
临床怎么用
- 作者认为这些载体可能作为序贯免疫策略的一部分,用于启动广谱中和抗体的产生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infection with HIV or SIV often elicits a potent immune response to viral antigens. This includes T cells and antibodies specific for Gag and Env antigens. In contrast, when given as a vaccine, the same antigens have been weak immunogens, unable to elicit antibodies with comparable titer, durability, or neutralizing activity. We have used the live attenuated rubella vaccine strain RA27/3 as a viral vector to express HIV and SIV antigens. By mimicking an HIV infection, these vectors could elicit stronger and more durable immunity to HIV antigens. The vectors are based on the licensed rubella vaccine strain, which has demonstrated safety and potency in millions of children. One or two doses protect for life against rubella infection. The question was whether rubella vectors could similarly enhance the immunogenicity of a foreign vaccine insert. We have previously reported that rubella vectors can express small protein antigens in vitro and in vivo, where they elicit a strong immune response to the vaccine insert. The vectors have now expressed larger vaccine inserts that include epitope-rich fragments of the Gag matrix and capsid proteins (aa 41-211) or the complete p27 capsid protein with p2 (aa 136-381). These vectors have elicited a robust and durable immune response to Gag in rhesus macaques. This size range also encompasses the engineered outer domain (eOD) of HIV envelope gp120 (172 amino acids). The rubella/eOD-GT6 and GT8 vectors stably expressed glycoproteins that bind germline precursors and mature forms of VRC01-class broadly neutralizing antibodies. These vectors potentially could be used as part of a sequential immunization strategy to initiate the production of broadly neutralizing antibodies.
引用
- Virnik K, Nesti E, Dail C, et al. Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors. Vaccine. 2017. PMID: 28483193. doi:10.1016/j.vaccine.2017.04.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。